Revaprazan Hydrochloride CAS 178307-42-1 Assay ≥99.0% API Factory High Purity
Kemikari Zita: Revaprazan Hydrochloride;Revaprazan HCL
CAS: 178307-42-1
API High Quality, Commercial Production
Chemical Name | Revaprazan Hydrochloride |
Mashoko anoreva zvakafanana | Revaprazan HCL |
Nhamba yeCAS | 178307-42-1 |
Nhamba yeCAT | RF-API48 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Mazana emaKilogram |
Molecular Formula | C22H24ClFN4 |
Molecular Weight | 398.904 |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Ichena kana Isina-White Crystalline Powder |
Solubility | Yakasununguka soluble mu chloroform, dichlormeth;Soluble muAcetic acid;Zvishoma soluble mu methanol, DMSO;Kashoma soluble muacetone, ACN;Inenge isinganyungudika mu 0.1mol/L NaOH mhinduro.0.1mol/L HCL mhinduro. |
Identification | Inofanira kupindurwa zvakanaka λ max 271nm, 205nm IR |
Melting Point | 219.0~222.0℃ |
Kujeka uye Ruvara | Inofanira kunge yakajeka uye isina ruvara mu dichlormeth |
Chloride | ≤8.93% |
Kusachena Kumwechete | ≤0.10% |
Zvose Zvisina Kuchena | ≤0.50% |
Kurasika paKuomesa | ≤0.50% |
Residue paIgnition | ≤0.10% |
Sulfate | ≤20ppm |
Arsenic | ≤10ppm |
Heavy Metals | ≤10ppm |
Assay | ≥99.0% |
Test Standard | Enterprise Standard |
Usage | Active Pharmaceutical Ingredient (API) |
Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.
Shanghai Ruifu Chemical Co., Ltd. ndiyo inotungamira mugadziri uye mutengesi weRevaprazan Hydrochloride (CAS: 178307-42-1) ine mhando yepamusoro.Revaprazan Hydrochloride inoderedza kutaura kweCOX-2 uye ine maitiro makuru e-anti-inflammatory action muH. pylori infection.Revaprazan Hydrochloride mukurapa duodenal ulcer, gastric ulcer uye gastritis.
Revaprazan Hydrochloride (inozivikanwawo sereversible proton pump inhibitors, potassium competitive acid blockers, p-CABs) chizvarwa chitsva che reversible proton pump inhibitors uye chete inotengeswa potassium inokwikwidza asidhi pombi inhibitors kana acid pump antagonists munyika.Yakagadzirwa nekambani yekuSouth Korea Yuhan uye iine kodzero dzepfuma yehungwaru, GLAxoSmithKline yakawana marezinesi ekusimudzira uye ekushambadzira emushonga pasi rose kunze kweSouth Korea neNorth Korea.Mushonga uyu wakatenderwa neSouth Korea FDA muna 2007 kurapa duodenal ulcers uye gastritis.